Clinical Trials Directory

Trials / Sponsors / Raziel Therapeutics Ltd.

Raziel Therapeutics Ltd.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedAn Open-label Study That Will Test a Second Treatment Session of RZL-012.
Submental Fat
Phase 22023-05-29
CompletedEvaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events
Submental Fat
Phase 1 / Phase 22022-09-25
CompletedAn Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese
Submental Fat
Phase 1 / Phase 22022-07-29
CompletedEvaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks
Flank Mass
Phase 22022-03-10
CompletedEfficacy and Safety of RZL-012 on Submental Fat Reduction
Submental Fat
Phase 22021-06-15
CompletedRZL-012 for Dercum's Disease Lipomas
Dercum's Disease Lipomas
Phase 22020-07-30
CompletedA Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Effi
Submental Fat
Phase 22020-02-25
CompletedTreatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease
Lipedema, Dercum Disease
Phase 22018-06-28
CompletedEvaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers
Obesity, Weight Loss, Overweight and Obesity
Phase 22017-07-25